Scientific Sessions 2024  /  Applying Advances in Risk Prediction to PREVENT CV Disease  /  External validation of PREVENT in a large health system
Logo

American Heart Association

  2
  0

Final ID:

External validation of PREVENT in a large health system

  • Go, Alan  ( KAISER PERMANENTE NORTHERN CAL , Pleasanton , California , United States )
    • Author Disclosures:
    Alan Go: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bristol Myers-Squibb:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Applying Advances in Risk Prediction to PREVENT CV Disease

Monday, 11/18/2024 , 01:30PM - 02:45PM

Cardiovascular Seminar

More abstracts on this topic:
Case: A young adult with low short term risk and high long term risk

Hariri Essa, Belanger Matthew

Using long term risk estimates to support CVD prevention efforts

Berry Jarett, Magnani Jared

More abstracts from these authors:
Prevalence, Clinical Characteristics, and Outcomes in Heart Failure with Improved Ejection Fraction by Chronological Age

Srikanth Kishan, Vasti Elena, Sandhu Alexander, Go Alan, Adatya Sirtaz, Bhatt Ankeet, Lee Keane, Parikh Rishi, Ambrosy Andrew, Tan Thida, Hamilton Steven, Vardeny Orly, Krishnaswami Ashok, Ku Ivy

Variation in Prevalence, Treatment, and Outcomes in Heart Failure with Improved Ejection Fraction by Race and Ethnicity

Chang Alex, Vasti Elena, Sandhu Alexander, Go Alan, Adatya Sirtaz, Bhatt Ankeet, Lee Keane, Parikh Rishi, Ambrosy Andrew, Tan Thida, Hamilton Steven, Pabon Porras Maria, Vardeny Orly, Ku Ivy

You have to be authorized to contact abstract author. Please, Login
Not Available